Learning Centre  | Contact Us  | Feedback  | Download | Careers  | Customer Care  | Market live
                 
Company Profile
 
You Are On : Home  |  Company Profile  |   Board Meetings
Board Meetings
Glenmark Pharmaceuticals Ltd.
 
Source DateBoard Meeting DateDetails
30-Oct-2024 14-Nov-2024 Quarterly Results
31-Jul-2024 14-Aug-2024 Quarterly Results
14-May-2024 24-May-2024 Audited Results & Final Dividend
30-Jan-2024 14-Feb-2024 Quarterly Results
31-Oct-2023 10-Nov-2023 Quarterly Results
31-Jul-2023 11-Aug-2023 Quarterly Results
03-May-2023 19-May-2023 Final Dividend & Audited Results
13-Jan-2023 10-Feb-2023 Quarterly Results
02-Nov-2022 11-Nov-2022 Quarterly Results
29-Jul-2022 10-Aug-2022 Quarterly Results
18-May-2022 27-May-2022 Final Dividend & Audited Results & Quarterly Results
02-Feb-2022 11-Feb-2022 Quarterly Results
01-Nov-2021 12-Nov-2021 Quarterly Results
05-Aug-2021 13-Aug-2021 Quarterly Results
19-May-2021 28-May-2021 Quarterly Results & Final Dividend & Audited Results
01-Feb-2021 12-Feb-2021 Quarterly Results & Inter alia, , to consider opportunistic tenders or buybacks of any part of its Singapore listed foreign currency convertible bonds, being, its U.S.$200 million (as on date outstanding U.S.$ 113.5 million) 2 per cent resettable onward starting equity linked securities due June 28, 2022 issuep in 2016 ("FCC Bonds"), based on market opportunities and conditions from time to time and to delegate powers to operations committee. The Operations Committee, based on market opportunities and conditions, will hold meetings to consider and approve the terms and conditions of any tenders or buybacks.
27-Oct-2020 06-Nov-2020 Quarterly Results
05-Aug-2020 14-Aug-2020 Quarterly Results
17-Jun-2020 26-Jun-2020 Dividend & Audited Results
31-Jan-2020 14-Feb-2020 Quarterly Results & The Board Meeting to be held on 14/02/2020 will, inter-alia, also consider and evaluate proposals for raising of funds either by issuance of bonds / debentures / non-convertible debt instruments or any other securities or any combination thereof, of any of the above, for refinancing of bonds/FCCBs/loans, in accordance with the FEMA ECB Guidelines, and other applicable regulations, guidelines and laws of India, and subject to all necessary regulatory, statutory and shareholder approvals, as may be required.
Page 1 of 6
Prev || Next
Compliance Officer  |  NOTICE  |  ATTN DP CLIENT  |   Arbitration Rule  |  Investor Grievance  |  BSE ITORS Disclaimer   |   Disclaimer |  Policy  |  Privacy Policy  |  Terms of Uses   Investor Charter |  MSSPL MAND |  MCSPL MAND
Multigain Financial Services Pvt. Ltd. ROC Reg No. U67190DL2004PTC130552, ARN # 31406
Multigain Securities Services Pvt Ltd. ROC Reg No.U74999UP2008PTC035558 Member National Stock Exchange Membership ID 13766 SEBI Reg # INB / INF / INE 231376634 Member Bombay Stock Exchange Membership ID 13766 SEBI Reg # INB / INF 011376630 Member MCX Stock Exchange. Membership No. 59500, SEBI Reg No.INE261330935 Member UNITED Stock Exchange Membership ID 13766 SEBI Reg # INE 271376634
Multigain Commodities Services Pvt Ltd ROC Reg No. U52100UP2008PTC035237 Member MCX Membership No. MCX/TM/ 9080 FMC Reg # MCX/TM/CORP/1694 Member NCDEX Membership No. NCDEX /TM/00926 FMC Reg No. NCDEX/TM/CORP/0903 Member NMCE Membership No. NMCE/TCM/CL0364 FMC Reg No. NMCE/TCM/CORP/0289 Member ICEX Membership No. ICEX/TM/1038 FMC Reg No. ICEX/TM/CORP/0037 Member ACE Membership No. ACE/TCM/6070 FMC Reg No. ACE/TCM/CORP/ Member NSEL Membership No. NSEL/TCM/12400 Member NCDEX SPOT
Copyright 2010-2011 Multigain Financial Services Pvt. Ltd. |   Designed , Developed and Content provided ACCORD FINTECH